Clinical Trials Sponsored by CSL Limited

Total 3503 results

Michael Campos, MD
CSL Behring

Completed

Effect of Double Dose of Alpha 1-antitrypsin Augmentation Therapy on Lung Inflammation.

Alpha 1 Antitrypsin Deficiency

United States
Thomas Jefferson University
Bristol-Myers Squibb; CSL Behring

Completed

Reversibility of Apixaban Anticoagulation With the Four Factor Prothrombin Complex Concentrate Kcentra (4PAR)

Thrombosis

United States
Acerand Therapeutics (Shanghai) Limited

Recruiting

Study of ACE-86225106 to Treat Patients With Advanced Solid Tumors

Breast Cancer | Ovarian Cancer | Prostate Cancer | BRCA1 Mutation | BRCA2 Mutation | Solid Tumor, Adult

China
Everstar Medicines (Shanghai) Limited

Completed

A Study of Ralinepag in Healthy Chinese Adult Subjects

Healthy Volunteer | Pharmacokinetic Study

China
LaNova Australia Pty Limited

Terminated

Study of LaNova Medicines(LM)-302 in Combination With Toripalimab in Patients With Advanced Solid Tumors

Advanced Solid Tumor

Australia
Lee's Pharmaceutical Limited
Zhaoke (Guangzhou) Pharmaceutical Limited

Completed

Bioequivalence Study of Azilsartan Tablets in Chinese Healthy Volunteers

Bioequivalence of Two Azilsartan Formulations

Hong Kong
SPD Development Company Limited
Richmond Pharmacology Limited

Completed

Urine Sample Collection From Non Pregnant Peri and Post-menopausal Women

Pregnancy
LaNova Australia Pty Limited

Recruiting

Study of LM-108 as a Single Agent or in Combination With Anti-PD-1 Antibody in Subjects With Advanced Solid Tumours

Advanced Solid Tumor

Australia
Lee's Pharmaceutical Limited
China Oncology Focus Limited

Withdrawn

Study of TG02 Citrate in Patients With Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma
Lee's Pharmaceutical Limited
Zhaoke (Hefei) Pharmaceutical Limited

Completed

A Study to Evaluate the Efficacy and Safety of Zingo in Chinese Children

Anesthesia, Local | Pain, Acute | Catheter Site Pain

China
Hutchison Medipharma Limited
Nutrition Science Partners Limited

Terminated

HMPL-004 Maintenance Treatment in Subjects With Mild to Moderate Ulcerative Colitis (NATRUL-4)

Ulcerative Colitis

United States
Pacific Edge Limited

Not yet recruiting

Study to Assess the Impact of the Urine Test Cxbladder Detect+ on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine. (CREDIBLE)

Hematuria - Cause Not Known
Bluedrop Medical Limited

Recruiting

Remote Monitoring of the Diabetic Foot to Prevent Re-Ulceration (MASTER)

Diabetic Foot

United States
Zydus Lifesciences Limited

Recruiting

Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ZYIL1 in Patients With Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis

India
Pacific Edge Limited

Recruiting

Detection and Risk Stratification in Veterans Presenting With Microscopic Hematuria (microDRIVE)

Urothelial Carcinoma

United States
Zydus Lifesciences Limited

Recruiting

A Study to Evaluate the Safety and Effectiveness of Saroglitazar 4 mg in Patients With NAFLD With Comorbidities

Obesity | Metabolic Syndrome | Dyslipidemias | Type 2 Diabetes | NAFLD

India
Lee's Pharmaceutical Limited

Not yet recruiting

Non-inferiority Study of ZK-A03 in Treatment of Herpes Zoster Before and After the Alteration of the Active Ingredient Manufacturer

Herpes Zoster
BLIS Technologies Limited

Recruiting

Assessment of Colonisation and Skin Quality Parameter Improvement by Probiotic Micrococcus Luteus Q24 Balm in Healthy Adults.

Microbial Colonization

New Zealand
BLIS Technologies Limited

Recruiting

Colonisation Efficacy of a Probiotic Chewing Gum.

Microbial Colonization

New Zealand
Vaccitech (UK) Limited

Recruiting

Prime-boost Immunotherapeutic Trial in Men With Biochemical Recurrence After Definitive Local Therapy for Prostate Cancer

Prostate Cancer

United States
Xeolas Pharmaceuticals Limited

Recruiting

A Randomized Control Trial Phase (IIIa) Unicentric, Placebo Controlled, Double-Blinded Efficacy and Safety of Topical Alendronic Acid on Alveolar Bone Remodeling After Tooth Extraction (XEOLAS)

Bone Loss, Alveolar

Spain
Smilebiotek Zhuhai Limited

Recruiting

QA108 Phase II Study in Subjects With Intermediate Age-Related Macular Degeneration

Intermediate Age-Related Macular Degeneration

China
SynOx Therapeutics Limited

Recruiting

Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT) (TANGENT)

TGCT

United States
BLIS Technologies Limited

Recruiting

Colonisation Efficacy of Oral Probiotic Fast Melt Powder

Microbial Colonization

New Zealand
Zydus Lifesciences Limited

Not yet recruiting

A Study to Evaluate Safety, Efficacy, Pharmacokinetics, and Immunogenicity of Test Pertuzumab (ZRC-3277, Cadila Healthcare Ltd.,)

Metastatic Breast Cancer
Aroa Biosurgery Limited

Recruiting

Myriad™ Augmented Soft Tissue Reconstruction Registry (MASTRR)

Hidradenitis Suppurativa | Anal Fistula | Pressure Injury | Pilonidal Sinus | Necrotizing Soft Tissue Infection | Abdominal Wound Dehiscence | Lower Extremity Wound

United States
Prestige Biopharma Limited

Recruiting

To Compare the Pharmacokinetics and Safety of PBP1502 and Humira in Healthy Subjects

Healthy Volunteers

Spain
Neuren Pharmaceuticals Limited

Recruiting

An Open-Label Study of Oral NNZ-2591 in Pitt Hopkins Syndrome (PTHS-001) (PTHS-001)

Pitt Hopkins Syndrome

United States
invoX Pharma Limited

Recruiting

FS222 First in Human Study in Patients With Advanced Malignancies

Metastatic Cancer | Advanced Cancer

Spain, Romania, Georgia
Lee's Pharmaceutical Limited

Not yet recruiting

A Phase II Study of Gimatecan (ST1481) in Locally Advanced or Metastatic Pancreatic Cancer

Pancreatic Cancer

China
RedHill Biopharma Limited

Not yet recruiting

Evaluate Safety and Efficacy of Rifamycin SV MMX in the Treatment of Traveler's Diarrhea in Children Age 6 to 11 Years

Traveler's Diarrhea
Lightpoint Medical Limited

Not yet recruiting

The LightPath® and 68Ga-RM2 in Breast Cancer Study

Breast Cancer

United Kingdom
Lee's Pharmaceutical Limited

Completed

A Study of Carboplatin Plus Etoposide With or Without ZKAB001 (Anti-PD-L1 Antibody) in Patients With ES-SCLC

Extensive-stage Small-cell Lung Cancer

China
LumiraDx UK Limited

Suspended

Sample Collection Study to Aid Evaluation of an Influenza A/B, Respiratory Syncytial Virus & COVID-19 Virus POC Test (INFORM)

Covid19 | RSV Infection | Influenza Type B | Influenza Type A

United Kingdom
Smilebiotek Zhuhai Limited

Active, not recruiting

QA102 Phase II Study in Subjects With Dry AMD (AMEND)

Dry Age-related Macular Degeneration

United States
Mundipharma Research Limited

Active, not recruiting

Study of Tinostamustine for Adjuvant Treatment of Glioblastoma

Glioblastoma Multiforme

Switzerland, Spain
Thirty Respiratory Limited

Withdrawn

PREvent Viral Exposure and Transmission Study: a COVID-19 (SARS-CoV-2) PEP Study (PREVENT) (PREVENT)

Respiratory Tract Diseases | COVID-19 Respiratory Infection | Respiratory Viral Infection

United Kingdom
Bluedrop Medical Limited

Completed

Use of Remote Thermovisual Monitoring in Patients With a Previous Diabetic Foot Ulcer

Diabetic Foot Ulcer

United Kingdom, Ireland
LumiraDx UK Limited

Active, not recruiting

Evaluation of the LumiraDx Point of Care D-Dimer and CRP Tests (NOVEL-3)

Inflammation | Embolism and Thrombosis | Infection

United States
Carrick Therapeutics Limited

Completed

Modular Study to Evaluate CT7001 Alone in Cancer Patients With Advanced Malignancies

Advanced Solid Malignancies

United States, United Kingdom
LaNova Medicines Limited

Withdrawn

Study of LM-305 in Patients With Relapsed or Refractory Multiple Myeloma (RRMM) and Other Plasma Cell Diseases

Relapsed or Refractory Multiple Myeloma | Other Plasma Cell Diseases
EnteraSense Limited
Databean

Completed

PillSense System for Detecting UGI Bleed

Upper Gastrointestinal Bleeding | Upper Gastrointestinal Bleed | UGI Bleed

United States
LaNova Medicines Limited

Terminated

Study of LM-108 as a Single Agent or in Combination With Pembrolizumab in Subjects With Advanced Solid Tumours

Advanced Solid Tumor

United States
LaNova Medicines Limited

Terminated

Study of LM-061 in Subjects in Advanced Tumors

Advanced Tumours

Australia
LumiraDx UK Limited

Completed

Performance Evaluation of the LumiraDx SARS-CoV-2 & FLU A/B and SARS-CoV-2 & RSV Tests for Aid in the Assessment of COVID-19 (INSPIRE-2)

COVID-19 | Influenza A | RSV Infection | Influenza Type B

United States
invoX Pharma Limited

Active, not recruiting

A Phase 1/2 Study of FS118 in Patients With Advanced Malignancies

Metastatic Cancer | Squamous Cell Carcinoma of Head and Neck | Advanced Cancer

United States, France
Skin Analytics Limited

Completed

DERM US and EU Validation Study

Basal Cell Carcinoma | Squamous Cell Carcinoma | Malignant Skin Melanoma T0

United States, Italy
Mina Alpha Limited

Active, not recruiting

A Study of MTL-CEBPA in Combination With a PD-1 Inhibitor in Patients With Advanced Solid Tumours (TIMEPOINT) (TIMEPOINT)

Solid Tumor, Adult

United Kingdom
DreamTec Research Limited

Completed

The Development of a COVID19 Oral Vaccine Consisting of Bacillus Subtilis Spores

COVID-19 Pneumonia

Hong Kong
Vivasure Medical Limited

Completed

PerQseal® Impella Early Feasibility Study

Percutaneous Large Hole Vascular Closure

United States

Clinical Trials Sponsored by CSL Limited

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Vietnam

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations